Theravance Biopharma, Inc. (TBPH) Stock buybacks 2023–2025
Theravance Biopharma, Inc. (TBPH) annual stock buyback history — cash paid to repurchase common stock, per SEC filings.
$445,000FY2025 · since FY2023: $128.8M → $445,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $445,000 | -99.8% |
| FY2024 | $197.1M | +53.0% |
| FY2023 | $128.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice